Freeline Therapeutics Holdings Price Prediction
| FRLNDelisted Stock | USD 4.31 0.28 6.10% |
Oversold Vs Overbought
68
Oversold | Overbought |
Using Freeline Therapeutics hype-based prediction, you can estimate the value of Freeline Therapeutics Holdings from the perspective of Freeline Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Freeline Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Freeline because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Freeline Therapeutics after-hype prediction price | USD 4.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Freeline |
Freeline Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Freeline Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Freeline Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Freeline Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Freeline Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Freeline Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Freeline Therapeutics' historical news coverage. Freeline Therapeutics' after-hype downside and upside margins for the prediction period are 4.31 and 4.31, respectively. We have considered Freeline Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Freeline Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Freeline Therapeutics is based on 3 months time horizon.
Freeline Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Freeline Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Freeline Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Freeline Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 6 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.31 | 4.31 | 0.00 |
|
Freeline Therapeutics Hype Timeline
Freeline Therapeutics is currently traded for 4.31. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Freeline is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Freeline Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 4.31. About 46.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.94. Some equities with similar Price to Book (P/B) outperform the market in the long run. Freeline Therapeutics recorded a loss per share of 11.4. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 12th of May 2023. Given the investment horizon of 90 days the next expected press release will be very soon. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.Freeline Therapeutics Related Hype Analysis
Having access to credible news sources related to Freeline Therapeutics' direct competition is more important than ever and may enhance your ability to predict Freeline Therapeutics' future price movements. Getting to know how Freeline Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Freeline Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNSP | Cns Pharmaceuticals | (0.01) | 6 per month | 0.00 | (0.06) | 9.09 | (8.33) | 39.29 | |
| ZVSA | ZyVersa Therapeutics | (0.1) | 4 per month | 0.00 | (0.15) | 7.57 | (9.60) | 78.93 | |
| EFTR | Effector Therapeutics | (0.06) | 4 per month | 0.00 | (0.31) | 8.70 | (27.78) | 88.91 | |
| VECT | VectivBio Holding AG | 0.06 | 7 per month | 0.88 | 0.19 | 5.61 | (3.08) | 39.30 | |
| AVRO | AVROBIO | 0.05 | 5 per month | 1.89 | 0.01 | 4.11 | (3.17) | 14.20 | |
| IMMX | Immix Biopharma | (0.04) | 4 per month | 4.54 | (0.01) | 9.38 | (8.22) | 32.68 | |
| HEPA | Hepion Pharmaceuticals | (0.02) | 4 per month | 0.00 | (0.05) | 8.06 | (8.11) | 33.54 | |
| NAVB | Navidea Biopharmaceuticals | 0.00 | 0 per month | 0.00 | (0.15) | 12.50 | (12.50) | 40.40 | |
| SONN | Sonnet Biotherapeutics Holdings | 1.15 | 6 per month | 0.00 | (0.17) | 12.31 | (9.79) | 37.58 |
Freeline Therapeutics Additional Predictive Modules
Most predictive techniques to examine Freeline price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Freeline using various technical indicators. When you analyze Freeline charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Freeline Therapeutics Predictive Indicators
The successful prediction of Freeline Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Freeline Therapeutics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Freeline Therapeutics based on analysis of Freeline Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Freeline Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Freeline Therapeutics's related companies.
Story Coverage note for Freeline Therapeutics
The number of cover stories for Freeline Therapeutics depends on current market conditions and Freeline Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Freeline Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Freeline Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Freeline Therapeutics Short Properties
Freeline Therapeutics' future price predictability will typically decrease when Freeline Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Freeline Therapeutics Holdings often depends not only on the future outlook of the potential Freeline Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Freeline Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4 M | |
| Cash And Short Term Investments | 47.3 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Freeline Stock
If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |